| Literature DB >> 35273233 |
Sunhyung Lee1, Taehong Kee1, Mi Yeon Jung1, Pil Whan Yoon2.
Abstract
A barbed suture is a self-anchoring knotless suture hypothesized to shorten suture time and reduce the tension point of the wound. The purpose of this study was to compare the barbed suture and the interrupted suture for fascial closure in total hip arthroplasty. We retrospectively reviewed patients who underwent total hip arthroplasty from March 2014 to June 2020. We evaluated 324 cases among 274 patients consisting of 188 males and 86 females. We collected the following data: demographics, time for wound closure, the number of threads used, hemoglobin level, surgical site pain, and wound complications. Variables were analyzed for their association with closure time using multiple regression analyses between the barbed suture (the SFX group) and the interrupted suture (the Vicryl group). Mean closure time was 5.8 min lower and the mean number of sutures used was 2.2 lower in the SFX group versus the Vicryl group (P < 0.01 and < 0.01, respectively). There were no statistical intergroup differences in the mean largest hemoglobin drop, the incidence of transfusion, surgical site pain, and the incidence of wound complications. The use of barbed sutures for fascial closure in total hip arthroplasty effectively reduces the surgical time without increasing wound complications.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35273233 PMCID: PMC8913744 DOI: 10.1038/s41598-022-07862-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1A flowchart for the surgical procedure, suture methods, and time intervals.
Patient demographics.
| Variables | SFX group (n = 126) | Vicryl group (n = 198) | Total (n = 324) | |
|---|---|---|---|---|
| 48.9 ± 14.1 | 52.2 ± 13.4 | 50.9 ± 13.8 | ||
| Male | 89 (70.6%) | 131 (66.2%) | 220 (68.0%) | |
| Female | 37 (29.4%) | 67 (33.8%) | 104 (32.0%) | 0.47b |
| Total | 126 (100%) | 198 (100%) | 324 (100%) | |
| BMI (kg/m2, mean ± SD) | 23.9 ± 3.6 | 23.9 ± 3.5 | 23.9 ± 3.5 | 0.93a |
| Never | 59 (46.8%) | 103 (52.0%) | 162 (50.0%) | |
| Ex-smoker | 29 (23.0%) | 63 (31.8%) | 92 (28.4%) | |
| Current smoker | 38 (30.2%) | 32 (16.2%) | 70 (21.6%) | |
| Total | 126 (100%) | 198 (100%) | 324 (100%) | |
| 15 (11.9%) | 11 (5.6%) | 26 (8.0%) | 0.07b | |
| 0.7 ± 1.3 | 0.5 ± 1.2 | 0.6 ± 1.2 | 0.43a | |
| No | 125 (99.2%) | 196 (99.0%) | 321 (99.1%) | |
| Yes | 1 (0.8%) | 2 (1.0%) | 3 (0.9%) | 1.00b |
| Total | 126 (100%) | 198 (100%) | 324 (100%) | |
| The second THA for staged THAs (n, %) | 11 (8.7%) | 29 (14.6%) | 40 (12.3%) | 0.12b |
Significant values are in bold.
SD, Standard deviation; BMI, body mass index; CCI, Charlson Comorbidity Index.
aBy independent t-test.
bBy chi-square test.
Surgical time and the number of threads used according to suture type of THA patients.
| Variables | SFX group (n = 126) | Vicryl group (n = 198) | |
|---|---|---|---|
| Closure time (min, mean ± SD) | 46.5 ± 10.5 | 52.3 ± 10.4 | < |
| Procedure duration (min, mean ± SD) | 74.8 ± 12.8 | 82.9 ± 14.5 | < |
| Total operation time (min, mean ± SD) | 130.7 ± 17.0 | 138.8 ± 18.3 | < |
| Number of used Vicryl (n, mean ± SD) | 3.1 ± 0.5 | 5.3 ± 1.4 | < |
Significant values are in bold.
aBy independent t-test.
SD, Standard deviation; Closure time, from intraoperative X-ray to skin closure; Procedure duration, from incision to skin closure; Total operation time, from anesthesia to exiting operation room.
Clinical outcomes according to suture type of THA patients.
| Variable | SFX group (n = 126) | Vicryl group (n = 198) | |
|---|---|---|---|
| − 2.5 ± 1.3 | − 2.6 ± 1.5 | 0.37a | |
| 12.8 ± 2.0 | 13.1 ± 1.8 | 0.12a | |
| 13.5 ± 1.6 | 13.4 ± 1.4 | 0.60a | |
| No | 109 (86.51%) | 154 (77.78%) | |
| Yes | 17 (13.49%) | 44 (22.22%) | 0.07b |
| Total | 126 (100%) | 198 (100%) | |
| Improvement in VAS (mean ± SD) | − 0.4 ± 0.9 | − 0.3 ± 0.7 | 0.07a |
Hb, hemoglobin; SD, standard deviation; VAS, Visual Analogue Scale.
aBy independaent t-test.
bBy chi-square test.
Wound related complications.
| Closure type | Type of complication | Number of reoperation | |
|---|---|---|---|
| Case 1 | SFX | Oozing, stitch abscess, and hematoma | 2 |
| Case 2 | Vicryl | Wound dehiscence | 1 |
| Case 3 | Vicryl | Hematoma | 0 |
| Case 4 | Vicryl | Stitch abscess | 0 |
SFX, fascial closure with Stratafix; Vicryl, fascial closure with Vicryl.
Multiple regression analysis for the closure time and wound complications.
| Variables | Univariable | Multivariable | ||
|---|---|---|---|---|
| Beta or crude OR (95% CI) | Beta or adjusted OR (95% CI) | |||
| Wound closure type | − 5.78 (− 8.02 to − 3.44) | − 5.81 (− 8.17 to − 3.44) | ||
| Age | 0.01 (− 0.08 to 0.09) | 0.84 | − 0.03 (− 0.11 to 0.06) | 0.52 |
| Gender | − 0.57(− 3.09 to 1.95) | 0.66 | − 1.19 (− 4.00 to 1.63) | 0.41 |
| History of smoking | − 0.79 (− 2.26 to 0.69) | 0.29 | − 0.81 (− 2.46 to 0.84) | 0.34 |
| BMI | 0.34 (0.01 to 0.67) | 0.35 (0.02 to 0.68) | ||
| CCI | 0.14 (− 0.82 to 1.11) | 0.77 | 0.34 (− 0.60 to 1.28) | 0.47 |
| Wound closure type | 0.52 (0.03 to 4.11) | 0.57 | 0.36 (0.01 to 5.33) | 0.51 |
| Age | 1.04 (0.97 to 1.14) | 0.32 | 1.06 (0.97 to 1.21) | 0.27 |
| Gender | 6.51 (0.82 to 132.39) | 0.11 | 24.51 (1.04 to 1825.27) | 0.09 |
| History of smoking | 0.68 (0.12 to 2.39) | 0.59 | 4.08 (0.38 to 58.61) | 0.25 |
| BMI | 1.39 (1.06 to 1.86) | 1.57 (1.12 to 2.55) | ||
| CCI | 1.28 (0.64 to 1.89) | 0.30 | 1.39 (0.72 to 2.30) | 0.20 |
Significant values are in bold.